MindMeld AI gets torn down, HarborTech gets underwritten, a pharma CEO has to choose. Strategy where somebody loses either way.
4 challenges20 models
20 models tested across 4 business strategy challenges.Composite score: 30% Rival Index, 20% task coverage, 20% challenge-scoped duel performance, 15% recency, 15% tier. Deduplicated by product line. GPT-6 Luna leads at 78.0/100. Drawn from Rival's open dataset of 21,000+ human preference votes.
Rival's PickOpenai flagship
Too close to callComposite scores combine task evidence, Rival Index, recency, and model tier. Rival’s Pick is a separate editorial recommendation. How ranking works
Opening lines from 6 answers across every prompt behind this ranking. Formatting stripped, words untouched.
Here's a pitch deck summary for a startup called "MindMeld AI": **Slide 1 - Vision:** "We're building the future of human-AI collaboration.…
“94% accuracy” and “predict what you want to type before you think it” Why it’s weak: This is the deck’s central technical claim, but “accuracy” is undefined: Is it word-level or character-level accuracy, measured on a fixed vocabulary or open-ended text, and under what conditions?Read the full answer
You are writing an internal investment committee memo for a long/short equity fund. Company (fictional): LedgerLift (ticker: LLLT) – B2B…
LedgerLift (LLLT) — Investment Committee Memo Recommendation: Short 12-month price target: $28–$42 At $46, LedgerLift’s price implies continued strong growth and margin expansion; our DCF scenarios value the shares at approximately $17–$42, with the base case near $28.Read the full answer
IC Memo: LedgerLift (LLLT) — B2B Spend Management SaaS Analyst: L/S Equity Fund Date: Internal draft Fictional exercise — not investment advice Recommendation SHORT. 12-month price target range: $32–$40 (current: $46).Read the full answer
You are underwriting a 5-year LBO for a private equity investment committee. Company (fictional): HarborTech Services (HTS) –…
HarborTech Services – LBO Underwriting Summary Entry Economics EV = 12.0x × $120m = $1,440m; fees = 2% × 1,440 = $28.8m; total uses = $1,468.8m Debt: Term Loan = 4.0x × 120 = $480m (9% cash, 1%/yr amort); Mezz = 1.5x × 120 = $180m (12% cash + 2% PIK) Sponsor equity = 1,468.8 − 660 = $808.8m (~55% of cap) Annual Model…Read the full answer
Here is the underwriting analysis for HarborTech Services (HTS). Transaction Summary & Sources & Uses Enterprise Value (EV): $120.0\text{m} \times 12.0\text{x} = \$1,440.0\text{m}$ Transaction Fees: $2.0\% \times \$1,440.0\text{m} = \$28.8\text{m}$ Total Uses: $\$1,440.0\text{m} + \$28.8\text{m} = \$1,468.8\text{m}$…Read the full answer
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, the guiding principle in this crisis is clear: Patient safety is non-negotiable, and transparency is the only viable long-term strategy for corporate survival.Read the full answer
